Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioblastoma × ipatasertib × Clear all

Phase

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Mouth Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Temozolomide 38 Radiotherapy 16 Radiation 11 Nivolumab 9 Magnetic Resonance Spectroscopy 9 Specimen Handling 7 pembrolizumab 6 Bevacizumab 6 atezolizumab 4 Lomustine 4 olaparib 3 Photons 3 Ipilimumab 3 Immunoglobulin G 3 Disulfides 3 Diet, Ketogenic 3 Cyclophosphamide 3 trametinib 2 sargramostim 2 poly ICLC 2 pamiparib 2 niraparib 2 dabrafenib 2 azeliragon 2 Transurethral Resection of Bladder 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Standard of Care 2 Receptors, Interleukin-8B 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03673787 2025-05-14

IceCAP

Institute of Cancer Research, United Kingdom

Phase 1/2 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡